CBID start-up, Glyscend Inc., is awarded $500,000
Glyscend was selected as a winner of the Johnson & Johnson World Without Disease QuickFire Challenge and awarded $500,000 for continuing efforts to bring innovative solutions to patients. Glyscend was selected as one of three winners from over 470 applications from entrepreneurs, researchers, and start-up companies from across the globe. Applications were assessed on the quality of technology, value proposition, […]